Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2. - Test2 - elhamkhani - TriplyDB

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.

http://www.wikidata.org/entity/Q34349806

about

Muscle wasting in myotonic dystrophies: a model of premature aging Deregulated microRNAs in myotonic dystrophy type 2 Abnormal splicing of NEDD4 in myotonic dystrophy type 2: possible link to statin adverse reactions.Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.A common gene expression signature in Huntington's disease patient brain regions.Alternative splicing of human insulin receptor gene (INSR) in type I and type II skeletal muscle fibers of patients with myotonic dystrophy type 1 and type 2.Quantifying cancer absolute risk and cancer mortality in the presence of competing events after a myotonic dystrophy diagnosis.Genome wide identification of aberrant alternative splicing events in myotonic dystrophy type 2.Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.Most expression and splicing changes in myotonic dystrophy type 1 and type 2 skeletal muscle are shared with other muscular dystrophies.Molecular therapy in myotonic dystrophy: focus on RNA gain-of-function.Repeat expansion diseases: when a good RNA turns bad.Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.(CCUG)n RNA toxicity in a Drosophila model of myotonic dystrophy type 2 (DM2) activates apoptosis.Myotonic Dystrophy Type 2: An Update on Clinical Aspects, Genetic and Pathomolecular Mechanism.Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.Biomolecular diagnosis of myotonic dystrophy type 2: a challenging approach.Altered MEF2 isoforms in myotonic dystrophy and other neuromuscular disorders.Alternative splicing alterations of Ca2+ handling genes are associated with Ca2+ signal dysregulation in myotonic dystrophy type 1 (DM1) and type 2 (DM2) myotubes.Prevalence and clinical correlates of sleep disordered breathing in myotonic dystrophy types 1 and 2.Misregulation of calcium-handling proteins promotes hyperactivation of calcineurin-NFAT signaling in skeletal muscle of DM1 mice.Abnormalities in Skeletal Muscle Myogenesis, Growth, and Regeneration in Myotonic Dystrophy.Bruno-3 regulates sarcomere component expression and contributes to muscle phenotypes of myotonic dystrophy type 1.

P2860

Q26798784-390178E5-5D78-4E58-8A28-D488E5C9FD5D Q28727681-2DE815A3-979C-460D-A663-ECCAE83F490C Q33978080-089D5927-E8E5-4F6E-A1C4-3D6A38B30FCB Q34358301-2810DF40-A40E-401F-B704-B4499253C75C Q34446889-011D9719-F26A-4E5A-9CD9-09AA0263F6D9 Q34716334-E572D798-2628-4B98-AD52-7C712B592725 Q35043905-1536B610-6D29-4A50-A9EB-6792CD6A9EC4 Q35145526-41077E4C-D812-41B5-9778-5983AF72FAAA Q37440074-AF5F2E01-7FDA-452A-B81B-6728EF5A34C8 Q37619968-5401E1D4-5E3F-4C71-B9B6-61199D92ACF2 Q37734660-8C89B651-87B6-444D-A7E3-744C59A14297 Q37940388-26CF4161-840A-4629-B049-00F9C1D7CAEA Q38209927-77172810-493B-4273-9F8E-C0794B6FACAB Q38721747-D7D99AD7-5D06-4BD0-8972-6AF165E7F650 Q39012035-BDCE19A6-A328-408C-BDE2-3C8F5BD7B3A4 Q39081415-422A6E84-B476-468C-AE0C-671D06440DCA Q39333700-7A31DCD4-5147-4FE4-9B3E-39DFCE6CEA6A Q42793424-D1641EE4-2E62-4C0D-ADFA-398930DA97C8 Q47929916-71B84DDF-0BD5-4963-B44F-02A898A6CB53 Q48138808-0C64FCEB-1F7C-41B8-88BD-C0F92BE73B1A Q50755664-515ECF48-D2E4-4E41-97CB-90D93116E1D7 Q54982478-9B4B1F26-7E2F-4214-BCBF-1C16EDCBE631 Q55322911-17D656F3-6F89-4EAE-9415-9F1F387EC4DF

P2860

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2.

http://www.wikidata.org/entity/Q34349806

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@ast

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@en

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@nl

type

label

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@ast

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@en

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@nl

prefLabel

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@ast

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@en

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@nl

P1433

Q34349806-993BD601-6961-4515-A008-D7783CCF2BE8

P1476

Q34349806-06D45EC2-57CA-453A-8613-23704042941A

P2093

Q34349806-14CD5AF6-3F79-4FBF-8100-98AD17877AE2

Q34349806-2A3D550C-82FB-4008-A92B-8B78487EC5A2

Q34349806-475449E5-0331-4F6C-9989-989A68165C86

Q34349806-4EAD1795-5CA8-4D8A-B5F2-3984DFB5F481

Q34349806-596CF35E-1D84-4DC4-9479-08A4F9CCFB2E

Q34349806-65147CC3-A579-4AF4-9D67-66E8F7609E84

Q34349806-72B149C4-0840-4252-B9D2-42C1A86EBC8F

Q34349806-75972B2B-64BB-46A7-A4F5-07865901814E

Q34349806-82D7885F-3BE0-4F66-8C5D-4198D10488A9

Q34349806-A54BF06D-EA2D-4A58-AB6B-880028726DB8

P2860

Q34349806-0476CF7C-A484-4558-B0CD-3CEE9C220715

Q34349806-0AACC92C-AD08-4EFF-B5C3-3EB79A1158A9

Q34349806-0D825A70-D407-4905-A09B-3A696BAA564D

Q34349806-13E9E8F9-8493-4133-BA33-B9237216C7FA

Q34349806-15348010-8699-4D3F-9E8B-5A3C1F315D4B

Q34349806-28A836BF-05C8-44BD-929A-ED462223F65E

Q34349806-29B3D770-2770-4FA2-B33E-A83050FF84F9

Q34349806-2AC6C987-57F3-4516-9489-5A243B0C6A94

Q34349806-2CD35402-1B38-43E0-9FB8-F1E73C3DA453

Q34349806-3596B345-F791-4AFF-8605-03603C979851

P2888

Q34349806-5556C51C-9BF2-41D2-90CA-368029BCA47D

P304

Q34349806-CD94B7C5-B660-484C-899E-D4A404BF8B52

P31

Q34349806-54ED04F4-E91A-4DC7-A530-3F2CFC57EEBD

P356

Q34349806-4AF58FA3-217D-41AA-AC46-D07093B770B8

P433

Q34349806-D53F43FB-625B-454D-992B-57B7065E6E26

P478

Q34349806-79508D2C-1788-4861-9F57-AD21E59750D5

P50

Q34349806-8512B822-1B13-4FED-A899-13F50F066713

P577

Q34349806-709959DB-7C30-4045-9B54-D9344FE557FE

P5875

Q34349806-135B7528-3327-412E-A341-53FB9665ED61

P6179

Q34349806-90C3806E-C2F9-44C5-B8AB-A6116EDE811A

P698

Q34349806-A64A69B6-CEC2-48E9-993A-9F6A162A1360

P932

Q34349806-32CDA9D8-FECE-4A35-B2E4-1D1FDBAF0087

P356

S00401-010-0637-6

P1433

Acta Neuropathologica

P1476

Differences in aberrant expres ...... tonic dystrophies DM1 and DM2.

@en

P2093

Anders Paetau

http://www.w3.org/2001/XMLSchema#string

Anna Vihola

http://www.w3.org/2001/XMLSchema#string

Bjarne Udd

http://www.w3.org/2001/XMLSchema#string

Hannu Haapasalo

http://www.w3.org/2001/XMLSchema#string

Hannu Kalimo

http://www.w3.org/2001/XMLSchema#string

Jeanette Holmlund-Hampf

http://www.w3.org/2001/XMLSchema#string

Keith A Baggerly

http://www.w3.org/2001/XMLSchema#string

Lars Edström

http://www.w3.org/2001/XMLSchema#string

Linda L Bachinski

http://www.w3.org/2001/XMLSchema#string

Mario Sirito

http://www.w3.org/2001/XMLSchema#string

P2860

Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity

ZASP: a new Z-band alternatively spliced PDZ-motif protein

Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells

Cloning of human RTEF-1, a transcriptional enhancer factor-1-related gene preferentially expressed in skeletal muscle: evidence for an ancient multigene family

Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy

CUG-BP binds to RNA substrates and recruits PARN deadenylase

Molecular basis for impaired muscle differentiation in myotonic dystrophy

Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype

Conserved GU-rich elements mediate mRNA decay by binding to CUG-binding protein 1

Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers

P2888

s00401-010-0637-6

P304

465-479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00401-010-0637-6

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40908926

http://www.w3.org/2001/XMLSchema#string

P6179

1005922890

http://www.w3.org/2001/XMLSchema#string

P698

20066428

http://www.w3.org/2001/XMLSchema#string

P932

4199327

http://www.w3.org/2001/XMLSchema#string